Please note most of these publications were published by our predecessor company CellPoint, LLC.

Cell>Point receives approval for Beta Cell Technology patent – 6/23/2009

CENTENNIAL, Colo., June 23, 2009 – Cell>Point today announced that the U.S.P.T.O. approved its Beta Cell Technology U.S. patent application (App. No. 10/942,615). Cell>Point’s Beta Cell Technology is currently in preclinical testing at The University of Chicago Medical Center for imaging Type I Diabetes.